CSIMarket



Harmony Biosciences Holdings inc.  (HRMY)
Other Ticker:  
 

Harmony Biosciences Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Change 94.81 % 98.84 % 91.92 % 60.78 % -
Y / Y Net Income Change 66.69 % 190.89 % - - -
Net Income (TTM) in Millions 58 49 35 10 22
Return On Equity (TTM) 29.07 % 28.66 % 24.15 % 8.25 % 20.18 %
Total Ranking # 568 # 584 # 746 # 854 # 857
Equity (TTM) in Millions 247 215 187 152 127
Seq. Equity Change 14.93 % 15.01 % 22.69 % 20.12 % 17.31 %
Seq. Net Income Change 9.52 % -5.41 % - - -


Roe Comment
Harmony Biosciences Holdings inc. returned in II. Quarter 29.07 % on shareholder's equity, a new company high.

ROE improved compare to previous quarter, due to net income growth.

Within Healthcare sector 56 other companies have achieved higher return on equity. While Return on equity total ranking has impoved so far to 573, from total ranking in previous quarter at 588.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 25
Sector # 57
Overall # 571

Return On Equity Statistics
High Average Low
29.07 %
22.06 %
8.25 %
(Jun 30 2022)   (Sep 30 2021)


Annual Return On Equity (Dec 31 2021)
2021
(Dec 31 2020)
2020



Total Equity in Millions 187 97 0 0 0
Y / Y Equity Change 91.92 % - - - -
Net Income in Millions 35 -37 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 18.55 % -38.02 % - - -





Annual Roe Comment
In 2021 ROE improved to 18.55 % compare to previous year, due to net income growth.


Financial Statements
Harmony Biosciences Holdings's Equity $ 247 Millions HRMY's Balance sheet
Harmony Biosciences Holdings's Income $ 24 Millions Quarterly HRMY's Income Statement
HRMY's Income by Division See HRMY's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
HRMY's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for HRMY's Competitors
Return On Equity for Harmony Biosciences Holdings's Suppliers
Roe for HRMY's Customers

You may also want to know
HRMY's Roa HRMY's Inventory Turnover Ratio HRMY's Growth Rates HRMY's Dividend Statistics
HRMY's Profitability Ratios HRMY's Asset Turnover Ratio HRMY's Dividend Growth
HRMY's Roi HRMY's Valuation Ratios HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio



Companies with similar Return On Equity at Jun 30 2022, within Healthcare Sector ROE
Sensus Healthcare Inc.  74.85 %
Tenet Healthcare Corp  74.11 %
Vir Biotechnology Inc.  68.86 %
Oncotelic Therapeutics Inc.  68.05 %
Biofrontera Inc.  65.87 %
Eli Lilly And Company  64.62 %
Iteos Therapeutics Inc.  60.26 %
180 Life Sciences Corp.  59.53 %
Vyne Therapeutics Inc.  54.91 %
Siga Technologies Inc  48.79 %
Glucotrack Inc.  47.72 %
Reflect Scientific Inc  47.53 %
National Research Corporation  45.39 %
Zoetis Inc.  45.24 %
Prophase Labs Inc.  43.98 %
Merck and Co. Inc.  41.90 %
Enact Holdings Inc.  41.81 %
Innoviva Inc.  38.87 %
Cryo cell International Inc.  38.23 %
Chemed Corporation  37.40 %
Quidelortho Corp  36.94 %
Pfizer Inc  36.26 %
Hanger inc.  34.41 %
Lftd Partners Inc.  33.22 %
Exelixis Inc.  32.88 %
Chemomab Therapeutics Ltd.  32.70 %
Hologic Inc  32.61 %
Fulgent Genetics Inc.  32.32 %
Agenus Inc  31.52 %
Organogenesis Holdings Inc.  31.48 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ANZU's Profile

Stock Price

ANZU's Financials

Business Description

Fundamentals

Charts & Quotes

ANZU's News

Suppliers

ANZU's Competitors

Customers & Markets

Economic Indicators

ANZU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071